Navigation Links
Organovo Reports Q3 2012 Financial Results, Provides Business Update
Date:11/16/2012

SAN DIEGO, Nov. 16, 2012 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo") a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported on its financial results for the three and nine month period ended September 30, 2012.

Third Quarter Corporate Highlights

  • National Institutes of Health three dimensional liver research grant revenue
  • Receipt of two issued patents, including Company's first assigned patent
  • Move to new, larger research and headquarters facility
  • Appointment of additional independent director to serve as Audit Committee Chairman
  • Third quarter 2012 revenues increased by $237,300 or approximately 102% over the same period in 2011, commensurate with the Company's continued delivery against collaborative research agreements and the initiation of research activities within the scope of a grant from the National Institutes of Health ("NIH").  Collaborative research agreement revenues contributed $141,800 or 60% of the revenue increase while grant revenues contributed $95,500.

    Cash receipts related to the reported revenues partially offset the Company's operating expenses and strengthened our balance sheet.  During the quarter the balance sheet was additionally strengthened through the receipt of approximately $1.7 million in capital from warrant and stock option exercises.  The Company had approximately $7.7 million cash on hand at the end of the quarter.  While the Company reported net earnings of approximately $38.5 million for the quarter, investors should note those earnings were primarily the result of a non-cash adjustment resulting from the change in fair value of our warrant liabilities.  The warrant liability is volatile in nature and is driven primarily by changes in the price of our Common stock, absent material changes in the number of warrants outstanding.  Investors should anticipat
    '/>"/>

    SOURCE Organovo Holdings, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
    2. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
    3. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
    4. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
    5. Organovo Announces Relocation and Commencement of Operations at Larger Facility
    6. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
    7. Organovo To Present At Lazard Healthcare Conference
    8. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    10. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    11. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/11/2014)... Texas , Sept. 11, 2014 XBiotech ... high throughput filling machine that the Company says will ... The fully integrated system is designed to fill, stopper ... the manufacturing process. Additionally, the unit is said to ... scanning system to provide a high level of quality ...
    (Date:9/11/2014)... 11, 2014 The Registration Committee ... is now open for Pittcon 2015, the world’s ... The event will be held March 8-12, 2015, ... Louisiana. , The discounted registration fee of ... after 2/20/2015). This affordable price includes unlimited week-long ...
    (Date:9/11/2014)... Francisco, California (PRWEB) September 11, 2014 ... of software and IT systems that support clinical ... Annotation™ (GVA™) Service that now supports the interpretation ... resulting in a single, user-friendly report that contains ... been used toward cancer treatment planning and support ...
    (Date:9/11/2014)... 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... that it intends to conduct a Private Placement ... funding its preclinical development activities and financial commitments ... The Company is proposing to complete a ... shares at a price of US$0.10 per Share, ...
    Breaking Biology Technology:Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 3Portage Announces Proposed Private Placement 2Portage Announces Proposed Private Placement 3Portage Announces Proposed Private Placement 4
    ... Five exceptional oncology nurses out of nearly 2,400 ... | US Oncology for their dedication to their ... Oncology Nursing Award honors those nurses in the United ... determination in providing the highest quality oncology nursing care to ...
    ... 22, 2011 The founders of Oncobiologics, Inc. today ... services, will launch itself to the biopharmaceutical industry at ... held June 27-30 at the Walter E. Washington Convention ... by a group of leading scientists and engineers from ...
    ... features below 100 nanometres have numerous applications ranging ... Tecnalia participates in a intragated FP7 European Project ... on nanoimprinting techniques (NIL), as a core aspect ... benefits followed are cost reduction, simpler fabrication process ...
    Cached Biology Technology:McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 2McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 3McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 4Oncobiologics, Inc. to Unveil New Biologics Proof-of-Concept Engine at BIO International Convention 2
    (Date:9/12/2014)... Melbourne researchers have discovered that cartilage plays an ... joints seen in rheumatoid arthritis, rather than being ... Tommy Liu, Professor Ian Wicks, Dr Kate Lawler, ... and Eliza Hall Institute made the discovery while ... controlling inflammation during rheumatoid arthritis. The study was ...
    (Date:9/12/2014)... Washington , September 12, 2014 ... source covering leading sectors including biometrics and mobile tech, issues ... launch of Apple Pay, its new payment service. ... founder of the Secure Identity and Biometrics Association (SIBA) and ... NXTD ) a company that is introducing its own ...
    (Date:9/11/2014)... deadly legacy of DDT, American peregrine falcons ( Falco ... biologists proposed to stop rearing young birds in captivity ... Doug Bell published models that year in ESA,s journal ... for the falcon in California, with and without direct ... that the birds would continue to recover without captive ...
    Breaking Biology News(10 mins):No innocent bystander: Cartilage contributes to arthritis 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 3Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 5Volunteer 'eyes on the skies' track peregrine falcon recovery in California 2Volunteer 'eyes on the skies' track peregrine falcon recovery in California 3Volunteer 'eyes on the skies' track peregrine falcon recovery in California 4Volunteer 'eyes on the skies' track peregrine falcon recovery in California 5
    ... in the fruitfly genome, Johns Hopkins scientists have identified those ... captured a global view of all the genes turned on ... to be published April 3 in Developmental Cell, has implications ... move similarly to spread beyond an original tumor, which are ...
    ... Italy and Virginia Tech in the United States have ... for the production xanthurenic acid (XA) in Anopheles gambiae, ... in the sexual reproduction of the malaria parasite (Plasmodium ... of XA could be an avenue for development of ...
    ... from a new, five-year study show that regular use of ... cancer by up to 71 percent and may offer similar ... , The study findings were released today at the ... Washington, D.C. , "We believe this is the first ...
    Cached Biology News:Researchers identify genes in fruitflies that may shed light on human cancer spread 2Oxidation defense in mosquitoes benefits malaria parasite 2COX-2 inhibitors significantly reduce risk of cancer 2
    Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
    Anti-Ephrin B1 Host: rabbit polyclonal Species Reactivity: human Applications: WB Storage: 4C...
    Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
    ...
    Biology Products: